Adjuvant Epirubicin Plus Cyclophosphamide Followed by Taxanes With or Without Carboplatin in Early-Stage Triple-Negative Breast Cancer (RJBC 1501): A Randomized Phase III Trial.

Journal:

Journal of Clinical Oncology

Published:

2025-12-11

DOI:

10.1200/jco-25-02412

Affiliations:

21

Authors:

25

Go to article

Institutions	Authors	Share
Ruijin Hospital, SJTU, China	6.000000	0.24
No.1 affiliated Hospital, ZCMU, China	1.000000	0.04
SUMC Affiliated Cancer Hospital, China	1.000000	0.04
Shaoxing Second Hospital, China	1.000000	0.04
International Peace Maternity and Child Health Hospital (IPMCH), SJTUSM, China	1.000000	0.04
Taizhou Central Hospital, China	1.000000	0.04
Lishui People's Hospital, China	1.000000	0.04
Guangdong Women and Children Hospital, China	1.000000	0.04
Stanford University School of Medicine, United States of America (USA)	1.000000	0.04
Jiangsu Jiangyin People’s Hospital, China	1.000000	0.04
Suzhou Ninth People's Hospital, China	1.000000	0.04
Foshan First People's Hospital, China	1.000000	0.04
The First Affiliated Hospital of Fujian Medical University, China	1.000000	0.04
Ningbo Women and Children’s Hospital, China	1.000000	0.04
Ruian People’s Hospital, China	1.000000	0.04
Fuding Hospital, China	1.000000	0.04
Ningbo Medical Center Li Huili Hospital, China	1.000000	0.04
Wenzhou People's Hospital, China	1.000000	0.04
Shangyu People's Hospital of Shaoxing, China	1.000000	0.04
Jiaxing University, China	0.500000	0.02
Jiaxing Maternity and Child Health Care Hospital, China	0.500000	0.02

Interested in Oncology and Carcinogenesis?